GlassScriptPhysician profile
Stephanie Hoffman
NPI 1063837235
$1,196.19
in general payments reported to CMS, 2019-2025
21 companies · $347 in 2025
The $347 reported for 2025 was more than what 78% of Women'S Health (Nurse Practitioner) providers received nationally (typical 2025 total: $123).
See the full distribution for Women's Health (Nurse Practitioner)
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $201 · 2022: $250 · 2023: $239 · 2024: $159 · 2025: $347.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $660 · Education: $84.99.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $660.18 |
| Education | $84.99 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Astellas Pharma US INC | $255.79 | 2022-2024 | Veozah, Myrbetriq |
| Abbvie INC. | $185.57 | 2021-2023 | |
| Sage Therapeutics, LLC | $94.15 | 2024-2025 | Zurzuvae |
| Exact Sciences Corporation | $76.72 | 2023-2025 | The Cologuard Plus Collection Kit, Cologuard Collection Kit |
| Exeltis, USA INC. | $74.84 | 2021-2024 | Slynd |
| Pacira Pharmaceuticals Incorporated | $65.72 | 2024-2025 | Exparel, Zilretta, Iovera |
| Mayne Pharma Commercial LLC | $58.08 | 2023-2025 | |
| Boston Scientific Corporation | $50.77 | 2025 | General - Therapies |
| Mylan Pharmaceuticals INC. | $45.83 | 2021-2022 | |
| Cardiva Medical, INC. | $44.50 | 2021-2023 | Cardiva Vascade Mvp Vvcs 6-12f |
| Daiichi Sankyo INC. | $39.71 | 2022-2025 | Injectafer |
| Optumhealth Care Solutions, LLC | $39.51 | 2025 | Vivify Health Care Team Portal 001, Eitan Medical |
| Exelixis INC. | $33.76 | 2023 | Cabometyx |
| Avion Pharmaceuticals | $24.56 | 2021-2022 | |
| Amgen INC. | $19.98 | 2025 | Evenity |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vertex Pharmaceuticals Incorporated | $18.62 | 2025 | |
| Hologic Sales and Service, LLC | $16.68 | 2025 | Aptima |
| Pfizer INC. | $13.81 | 2024 | |
| Ethicon US, LLC | $13.53 | 2021 | |
| Agile Therapeutics, INC. | $12.56 | 2022 | |
| Myovant Sciences INC. | $11.50 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Stephanie Hoffman listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.